Metformin induced autophagy in diabetes mellitus – Tuberculosis co-infection patients: A case study

• Main Authors: Bernadette Dian Novita Dewi, NIM011317017307, Mulyohadi Ali, Agung Pranoto, NIDN. 0004015605, Endang Isbandiati Soediono, Ni Made Mertaniasih, NIDN. 0007035703
• Format: Article PeerReviewed
• Language: English; English; English
• Published: ELSEVIER 2019
• Subjects: R Medicine (General); RC Internal medicine; RC306-320.5 Tuberculosis
• Online Access: http://repository.unair.ac.id/86088/1/Metformin%20induced_compressed.pdf; http://repository.unair.ac.id/86088/2/Metformin%20induced%20autopaghy%20in%20diabetes%20mellitus-tuberculosis.pdf; http://repository.unair.ac.id/86088/3/Metformin%20induced%20autophagy.pdf; http://repository.unair.ac.id/86088/; https://www.sciencedirect.com/science/article/pii/S001957071730286X; https://doi.org/10.1016/j.ijtb.2018.04.003
• Institution: Universitas Airlangga

Metformin (MET) is a potential combination drug to elevate anti-TB efficacy. However, the clinical effect, especially smear reversion, during metformin applied with anti-tuberculosis and insulin in patients with type 2 DM newly TB co-infection were remain unknown. An observational clinical study was...